Cite
HARVARD Citation
Ganguly, M. et al. (2020). Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform. Vaccine. 38 (52), pp. 8379-8386. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ganguly, M. et al. (2020). Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform. Vaccine. 38 (52), pp. 8379-8386. [Online].